Osaic Holdings’s Amplify Weight Loss Drug & Treatment ETF THNR Stock Holding History
Bought
Maintained
Sold
Other funds holding THNR
Osaic Holdings's THNR Position: Q3 2026 in Review
Osaic Holdings held its Amplify Weight Loss Drug & Treatment ETF (THNR) position steady in Q3 2026 at 356 shares worth $8.95K. The position accounts for ﹤0.01% of the portfolio, ranked #6691.
Osaic Holdings first reported a position in THNR in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.14K in Q2 2026. 6 funds tracked by Wall St. Rank hold THNR as of Q3 2026.
- Osaic Holdings held 356 shares of Amplify Weight Loss Drug & Treatment ETF worth $8.95K as of Q3 2026.
- Osaic Holdings left its Amplify Weight Loss Drug & Treatment ETF share count unchanged in Q3 2026.
- Amplify Weight Loss Drug & Treatment ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6691 holding.
- Osaic Holdings first reported a position in Amplify Weight Loss Drug & Treatment ETF in Q2 2026 and has held it in 2 quarters since.
- Osaic Holdings's Amplify Weight Loss Drug & Treatment ETF position peaked at $9.14K in Q2 2026.
- 6 funds tracked by Wall St. Rank held Amplify Weight Loss Drug & Treatment ETF as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.